Skip to main content

Table 3 Patient operation and postoperative data

From: Effect of body mass index on clinical outcomes after robotic cardiac surgery: is there an obesity paradox?

Variable

Normal

Lean

Overweight

and 0bese

P-value

(n = 81)

(n = 17)

(n = 48)

 

Operative time, min

331.38 ± 116.84

339.24 ± 97.19

381.67 ± 129.92

0.068

CPB time, min

126.19 ± 77.46

138.41 ± 82.35

157.98 ± 86.63

0.102

Cross-clamp time, min

73.69 ± 59.92

85.94 ± 65.58

89.79 ± 65.72

0.344

Intraoperative RBC transfusion ≥ 800ml, n(%)

11(13.58)

2(11.76)

4(8.33)

0.673

Intraoperative plasma transfusion ≥ 800ml, n(%)

3(3.71)

0(0)

4(8.33)

0.308

Drainage on postoperative day 1, ml

354.88 ± 323.03

356.76 ± 338.55

347.71 ± 294.76

0.991

Tracheal intubation time, h

13.17 ± 7.43

13.85 ± 7.63

14.93 ± 7.43

0.433

Intensive care unit stay, h

52.99 ± 17.33

56.18 ± 29.19

61.43 ± 23.33

0.092

Postoperative hospital

stay, day

9.01 ± 2.71

9.76 ± 5.83

10.65 ± 4.67

0.072

Postoperative high-dose transfusion, n(%)

12(14.81)

2(11.76)

7(14.58)

0.948

Arrhythmia, n(%)

10(12.34)

2(11.76)

11(22.92)

0.254

Pulmonary infection, n(%)

25(30.86)

3(17.65)

18(37.50)

0.317

CSA-AKI, n(%)

15(18.52)

3(17.65)

19(39.58)

0.021

Hepatic impairment, n(%)

11(13.58)

1(5.88)

12(25.00)

0.111

Abnormal bilirubin metabolism, n(%)

51(62.96)

12(70.59)

32(66.67)

0.806

Hypoalbuminaemia, n(%)

43(53.08)

11(64.71)

29(60.42)

0.570

Hypoprealbuminaemia, n(%)

13(16.05)

6(35.29)

7(14.58)

0.133

  1. P < 0.05, compared to normal body mass index patients
  2. CPB Cardiopulmonary bypass, CSA-AKI Acute kidney injury associated with cardiac surgery, RBC Red blood cells.